Nitric oxide production and inducible nitric oxide synthase expression in systemic sclerosis

Journal of Rheumatology

Volumn 25, Issue 2, 1998, Pages 314-317

  Yamamoto, Toshiyuki ^a   Katayama, Ichiro ^a   Nishioka, Kiyoshi ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Inducible nitric oxide synthase; Nitric oxide; Systemic sclerosis

Indexed keywords

MESSENGER RNA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYSTEMIC SCLEROSIS;

EID: 0031911728     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Fleischmajer R, Perlish JS, Reeves JRT. Cellular infiltrates in scleroderma skin. Arthritis Rheum 1977;20:975-84.
2. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991;43:109-42.
3. Vladutiu AO. Role of nitric oxide in autoimmunity. Clin Immunol Immunopathol 1995;76:1-11.
4. Clancy RM, Abramson SB. Nitric oxide - a novel mediator of inflammation. Proc Soc Exp Biol Med 1995;210:93-101.
5. Masi AT, Rodnan GP, Medsger TA. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980;23:581-90.
6. Barnett AJ, Miller MH, Littlejohn GO. A survival study of patients with scleroderma diagnosed over 30 years (1953-1983): The value of a simple cutaneous classification in the early stages of the disease. J Rheumatol 1988;15:276-83.
7. Yamamoto T, Katayama I, Nishioka K. Involvement of basic fibroblast growth factor in fibroblast stimulatory serum activity of a patient with systemic lupus erythematosus and multiple dermatofibromas. Dermatology 1995;191:281-5.
8. Sakurai H, Kohsaka H, Liu M-F, et al. Nitric oxide production and inducible nitric oxide synthase expression in inflammatory arthritides. J Clin Invest 1995;96:2357-63.
9. Roumm AD, Whiteside TL, Medsger TA Jr, Rodnan GP. Lymphocytes in the skin of patients with progressive systemic sclerosis. Arthritis Rheum 1984;27:645-53.
10. Gruetter CA, Barry BK, McNamara DB, Gruetter DY, Kadowitz PJ, Ignarro LJ. Relaxation of bovine coronary artery and activation of coronary arterial guanylate cyclase by nitric oxide, nitroprusside, and carcinogenic nitrosoamine. J Cyclic Nucleotide Res 1979;5:211-4.
11. Mellion BT, Ignarro LJ, Ohlstein EH, Pontocorvo EG, Hyman AL, Kadowitz PJ. Evidence for the inhibitory role of guanosine 3′5′-cyclic monophosphate in ADP-induced human platelet aggregation in the presence of nitric oxide and related vasodilators. Blood 1981;57:946-55.
12. Radomski MW, Palmer RMJ, Moncada S. Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide, and prostacyclin platelets. Br J Pharmacol 1987;92:639-46.
13. Jorens PG, Van Overveld FJ, Vermeire PA, Bult H, Herman AG. Synergism between interleukin-1 and interferon-γ, an inducer of nitric oxide synthase, in rat lung fibroblasts. Eur J Pharmacol 1992;224:7-12.
14. Schaffer MR, Tantry U, Gross SS, Wasserkrug HL, Barbul A. Nitric oxide regulates wound healing. J Surg Res 1996;63:237-40.
15. Wang R, Ghahary A, Shen YJ, Scott PG, Tredget EE. Human dermal fibroblasts produce nitric oxide and express both constitutive and inducible nitric oxide synthase isoforms. J Invest Dermatol 1996;106:419-27.
16. Kahaleh M. Endothelin, an endothelial-dependent vasoconstrictor in scleroderma. Arthritis Rheum 1991;34:978-83.
17. Kikuchi K, Kadono T, Sato S, Tamaki K, Takehara K. Impaired growth response to endothelin-1 in scleroderma fibroblasts. Biochem Biophys Res Commun 1995;207:829-38.
18. Zamora MR, O'Brien RF, Rutherford RB, Weil JV. Serum endothelin-1 concentrations and cold provocation in primary Raynaud's phenomenon. Lancet 1990;336:1144-7.
19. Kanno K, Hirata Y, Emori T. et al. Endothelin and Raynaud's phenomenon. Am J Med 1991;90:130-2.
20. Peacock AJ, Dawes KE, Shock A, Gray AJ, Reeves JT, Laurent GJ. Endothelin-1 and endothelin-3 induce chemotaxis and replication of pulmonary artery fibroblasts. Am J Respir Cell Mol Biol 1992;7:492-9.
21. Scott-Burden T, Schini VB, Elizondo E, Junquero DC, Vanhoutte PM. Platelet derived growth factor suppress and fibroblast growth factor enhances cytokine-induced production of nitric oxide by cultured smooth muscle cells. Effects on cell proliferation. Circ Res 1992;71:1088-100.
22. Vodovotz Y, Bogdan C, Paik J, Xie Q, Nathan C. Mechanisms of suppression of macrophage nitric oxide release by transforming growth factor β. J Exp Med 1993;178:605-13.
23. Nussler AK, Billiar TR. Inflammation, immunoregulation, and inducible nitric oxide synthase. J Leukocyte Biol 1993;54:171-8.